FDA NDC Directory · JSON-LD · Markdown

VIJOICE

NDC 0078-1028 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namealpelisib
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA215039
Dosage form / routeTABLET · ORAL
Active ingredientsALPELISIB (125 mg/1)
Marketing started20220405
Package count2

External sources

Source: openFDA. Public-domain (CC0).